Up to 20% of the CLTI population is estimated to be unreconstructable by means of conventional revascularization techniques due to the absence of a viable target vessel or viable conduit, or the presence of other comorbidities. Without any possibility of revascularization, such “no-option” patients have a dire prognosis, and suffer a high burden of major amputation and mortality.
Up to 20% of the CLTI population is estimated to be unreconstructable by means of conventional revascularization techniques due to the absence of a viable target vessel or viable conduit, or the presence of other comorbidities. Without any possibility of revascularization, such “no-option” patients have a dire prognosis, and suffer a high burden of major amputation and mortality.
Percutaneous deep vein arterialization (pDVA) has recently been shown to provide a promising treatment alternative for no-option patients.
File Name | Type | Permissions | Changed Date | Date | Size | ||||
---|---|---|---|---|---|---|---|---|---|
pdf |
Promis I | 0644 | 2025070109252101-Jul-2025 09:25 | 2023032308340423-Mar-2023 08:34 | 1 MB | Preview | Download | ||
pdf |
et0515 F8 Kum | 0644 | 2025070109252101-Jul-2025 09:25 | 2022122604531926-Dec-2022 04:53 | 988 KB | Preview | Download | ||
pdf |
et0521 FT LimFlow | 0644 | 2025070109252101-Jul-2025 09:25 | 2022122604532026-Dec-2022 04:53 | 2 MB | Preview | Download | ||
pdf |
manzi2011 | 0644 | 2025070109252101-Jul-2025 09:25 | 2022122604531926-Dec-2022 04:53 | 3 MB | Preview | Download |